Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
job cuts
Biotech
Xoma adds another struggling biotech to its buyout roster
After Generation Bio telegraphed major layoffs this summer, Xoma Royalty has come knocking to bring yet another ailing biotech into its fold.
Fraiser Kansteiner
Dec 16, 2025 11:00am
Genetic medicines biotech halves team
Nov 20, 2025 10:15am
Applied lays off 46% of workforce as rare disease plans stall
Nov 20, 2025 9:10am
Charles River lays off 70 staffers as strategic shift begins
Nov 14, 2025 4:40pm
Sensei shrinks workforce by 65% as layoff warning comes to pass
Nov 14, 2025 10:33am
Metagenomi sheds 25% of workforce, including CEO
Nov 12, 2025 6:30am
